Company attributes
Location
B2X
0
Pitchbook URL
Legal Name
AM-Pharma B.V.
Number of Employees (Ranges)
11 – 500
Number of Employees
40
Full Address
Stadsplateau 6, Utrecht, NL
Investors
Founded Date
2002
Email Address
info@am-pharma.com
Phone Number
+31302289222
Total Funding Amount (USD)
302,843,400
Latest Funding Round Date
July 16, 2019
Latest Funding Type
Patents Assigned (Count)
5
Country
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
130,000,000
Public/Private
Private
Previously, the company developed and tested a bovine form of AP in three phase II trials in patients with sepsis, AKI and UC.AM-Pharma has since developed and manufactured a proprietary and fully human recombinant form of AP, known as recAP.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.